Successful use of ursodeoxycholic acid in nodular regenerative hyperplasia of the liver

Annals of Pharmacotherapy

Volumn 45, Issue 4, 2011, Pages

  Ranucci, Giusy ^a   Cirillo, Francesco ^a   Corte, Claudia Della ^a   Vecchione, Raffaella ^a   Vallone, Gianfranco ^a   Iorio, Raffaele ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Liver function tests; Nodular regenerative hyperplasia of the liver; Portal hypertension; Ursodeoxycholic acid

Indexed keywords

AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; URSODEOXYCHOLIC ACID;

ADOLESCENT; ARTICLE; CASE REPORT; CHOLESTASIS; GASTROSCOPY; HUMAN; HUMAN TISSUE; LABORATORY TEST; LIVER BIOPSY; LIVER HYPERPLASIA; MALE; NEUTROPENIA; NODULAR REGENERATIVE HYPERPLASIA OF THE LIVER; PORTAL HYPERTENSION; PRIORITY JOURNAL; SPLENOMEGALY; THROMBOCYTOPENIA; ULTRASOUND;

ADOLESCENT; FOCAL NODULAR HYPERPLASIA; HUMANS; HYPERTENSION, PORTAL; MALE; URSODEOXYCHOLIC ACID;

EID: 79955560045     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1P742     Document Type: Article

References (13)

1. Reshamwala PA, Kleiner DE, Heller T. Nodular regenerative hyperplasia: not all nodules are created equal. Hepatology 2006;44:7-14.
2. Wanless IR. Micronodular transformation (nodular regenerative hyperplasia) of the liver: a report of 64 cases among 2,500 autopsies and a new classification of benign hepatocellular nodules. Hepatology 1990;11:787-97.
3. Trenschel GM, Schubert A, Dries V. Nodular regenerative hyperplasia of the liver: case report of a 13-year-old girl and review of the literature. Pediatr Radiol 2000;30:64-8.
4. Daniel F, Cadranel JF, Seksik P, et al. Azathioprine induced nodular regenerative hyperplasia in IBD patients. Gastroenterol Clin Biol 2005; 29:600-3.
5. Moriyasu F, Nishida O, Ban N, et al. "Congestion index" of portal vein. AJR Am J Roentgenol 1986;146:735-9.
6. Ferenci P, Caca K, Loudianos G, et al. Diagnosis and phenotypic classification of Wilson disease. Liver Int 2003;23:139-42.
7. Iorio R, Terracciano LM, Vecchione R, et al. An adolescent with multinodular liver at ultrasound scanning. J Pediatr Gastroenterol Nutr 2000; 31:566-9.
8. Faust D, Fellbaum C, Zeuzem S, et al. Nodular regenerative hyperplasia of the liver: a rare differential diagnosis of cholestasis with response to ursodeoxycholic acid. Z Gastroenterol 2003;41:255-8.
9. Kumar D, Tandon RK. Use of ursodeoxycholic acid in liver diseases. J Gastroenterol Hepatol 2001;16:3-14.
10. Amaral JD, Castro RE, Steer CJ, et al. p53 and the regulation of hepatocyte apoptosis: implications for disease pathogenesis. Trends Mol Med 2009;15:531-41.
11. Yang YY, Huang YT, Lee KC, et al. Chronic administration of ursodeoxycholic acid decreases portal pressure in rats with biliary cirrhosis. Clin Sci (Lond) 2009;116:71-9.
12. Ma J, Iida H, Jo T, et al. Ursodeoxycholic acid inhibits endothelin-1 production in human vascular endothelial cells. Eur J Pharmacol 2004;505:67-74.
13. Huet PM, Vincent C, Deslaurier J, et al. Portal hypertension and primary biliary cirrhosis: effect of long-term ursodeoxycholic acid treatment. Gastroenterology 2008;135:1552-60.